Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
3(27%)
Results Posted
14%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
5
45%
Ph phase_1
6
55%

Phase Distribution

6

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
6(54.5%)
Phase 3Large-scale testing
5(45.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting2
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (54.5%)
Phase 35 (45.5%)

Trials by Status

terminated19%
active_not_recruiting19%
completed764%
recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11